Not Yet RecruitingNot Applicable

Turkish Validation of the ALOC Screening Scale in Older Adults

Turkey (Türkiye)300 participantsStarted 2026-09-01

Plain-language summary

As the elderly population increases, health problems related to aging are also increasing. Loss of appetite negatively affects public health by causing malnutrition and related health problems in elderly individuals. Loss of appetite is a common problem in older adults, both in individuals with and without cognitive impairment. This can lead to serious health problems such as malnutrition, weight loss, muscle loss, weakening of the immune system and decreased quality of life. Cognitive disorders such as Alzheimer's and dementia can trigger loss of appetite, or loss of appetite can be a symptom of these disorders. Factors such as metabolic changes during the aging process, decreased sense of taste and smell, loneliness and depression contribute to loss of appetite. However, there is no valid and reliable scale in Turkey for the early diagnosis and assessment of loss of appetite. A scale being valid and reliable means that it can measure the concept it is intended to measure accurately and consistently. The aim of this study was to determine the validity and reliability of the Turkish version of the Loss of Appetite Scale in older adults with and without cognitive impairment .

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Elderly over 65 years, with or without cognitive impairment Exclusion Criteria: \-

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Validity and Reliability of the Turkish Version of the Appetite Loss in Older Adults With and Without Cognitive Impairment (ALOC) Screening Scale

Timeframe: From enrollment to the end of treatment at 12 weeks

Trial details

NCT IDNCT07147439

SponsorToros University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-11-01

Contact for this trial

Betül Gülşen, Assoc.Prof

+905322837384 betul.atalay@toros.edu.tr

View on ClinicalTrials.gov More Elderly (People Aged 65 or More) trials

Plain-language summary